Population
832 patients receiving a bone marrow transplant at the University of Minnesota between 1976 and 1988…
Design
Cohort
Authors
Loading...
May warrant age-stratified monitoring in neutropenic transplant recipients with viridans streptococcal bacteremia; leaves open prospective validation of pediatric risk.
Viridans streptococcal bacteremia can cause a rapidly progressive, often fatal shock syndrome in neutropenic bone marrow transplant patients, particularly in those younger than 15 years.
Steiner et al. (1993) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: